Showing 34,980 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

PrEP programmes & uptake

Injectable PrEP tops list as the preferred choice for adolescent girls in Cape Town

Editor's pick
Be In The Know
20 November 2020
Government, leadership & policy

NYC’s Leather Daddy HIV Czar Is Going to the CDC—And Advocates Nationwide Are Thrilled

Editor's pick
TheBody
20 November 2020
Tuberculosis & HIV

TB policies aren't working. Here's why.

Editor's pick
Devex
20 November 2020
New & experimental HIV treatments

Data sets up 2021 filings for Gilead's twice-a-year HIV drug lenacapavir

Editor's pick
Pharmaphorum
20 November 2020
Sexually transmitted infections prevention

DoxyPEP for STIs: Are We Ready for Prophylactic Doxycycline for MSM on HIV PrEP?

Editor's pick
TheBodyPro
20 November 2020
Injectable & long-acting HIV treatment

A Long-Lasting, More Effective HIV Drug Is A Psychological Relief For Patients

Editor's pick
NPR
20 November 2020
New & experimental HIV treatments

Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV

Editor's pick
Gilead press release
20 November 2020
HIV treatment for children & young people

WHO and other stakeholders join forces to accelerate access to effective paediatric HIV and tuberculosis diagnostics and medicines

Editor's pick
World Health Organization
20 November 2020
Harm reduction

Harm Reduction “Satellite Sites” Are a Powerful, Underutilized Model

Editor's pick
Filter
20 November 2020
Treatment outcomes & life expectancy

H.I.V. Death Rates Fell by Half 2010-2018, C.D.C. Says

Editor's pick
New York Times
20 November 2020
Sexually transmitted infections prevention

Almost one in ten HIV PrEP users report buying antibiotics for STI prevention, raising concerns over potential antibiotic resistance

News
20 November 2020
Coronavirus

aidsmapCHAT: series 3, episode 2 Video

November 2020
Ageing & HIV

How should we care for older people with HIV?

News
19 November 2020
PrEP programmes & uptake

'Uptake Is Only the First Step' for Effective HIV PrEP Protection

Editor's pick
Medscape (requires free registration)
18 November 2020
Hepatitis C transmission & prevention

WHO-commissioned global systematic review finds high HCV prevalence and incidence among men who have sex with men

Editor's pick
World Health Organization
18 November 2020
Epidemiology

HIV death rate in South African men much higher than in women

Editor's pick
Spotlight
18 November 2020
Treatment outcomes & life expectancy

Millions of people are on treatment for HIV: why are so many still dying?

Editor's pick
The Conversation
18 November 2020
HIV in the arts & media

This is what The Crown gets very right and very wrong about Princess Diana and the AIDS crisis

Editor's pick
Pink News
18 November 2020
HIV testing programmes & uptake

Almost half of HIV diagnoses in Europe are late, with serious impact on health outcomes

News
18 November 2020
Government, leadership & policy

As the Trump Era Ends, HIV Activists Need to Go Big or Go Home

Editor's pick
TheBody
17 November 2020
Injectable & long-acting PrEP

ViiV Healthcare receives FDA Breakthrough Therapy Designation for investigational, long-acting cabotegravir for HIV prevention

Editor's pick
ViiV press release
17 November 2020
Government, leadership & policy

Trump Administration Moves to Entrench Global Gag Rule

Editor's pick
Human Rights Watch
17 November 2020
Cancer

WHO releases new estimates of the global burden of cervical cancer associated with HIV

Editor's pick
World Health Organization
17 November 2020
Cancer

HIV is an independent risk factor for smoking-related cancers, especially in women

News
17 November 2020